Author:
Chen Yue-Yun,Wang Pei-Pei,Fu Yang-,Li Qing-,Tian Jiang-Fang,Liu Ting-,Lin Zhen,Ding Zhen-Yu
Reference34 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA,2018
2. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J. Clin. Oncol.,2008
3. Gefitinib or Chemotherapy for Non–SmallCell Lung Cancer with Mutated EGFR;Maemondo;N. Engl. J. Med.,2010
4. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol.,2011
5. Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial;Shi;Lancet Oncol.,2013
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献